Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan P Schneider

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
NPJ Genomic Medicine|October 13, 2023
Clinically significant germline pathogenic variants are missed by tumor genomic sequencingLeigh Anne Stout, Cynthia Hunter, Courtney Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158Tarah J Ballinger, Guanglong Jiang, Nawal Kassem, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 16, 2015
Incremental prognostic value of echocardiographic strain and its association with mortality in cancer patientsIsaac B Rhea, Sarada Uppuluri, Stephen Sawada, et al.
Scientific Reports|August 17, 2024
Optimization of a human induced pluripotent stem cell-derived sensory neuron model for the in vitro evaluation of taxane-induced neurotoxicityErica L Cantor, Fei Shen, Guanglong Jiang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 30, 2023
Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic DevelopmentTimothy A Yap, Zsofia K Stadler, Leigh Anne Stout, et al.
NPJ Breast Cancer|October 8, 2024
Discerning the impact of ctDNA detection on patient decision-making in early-stage breast cancerTarah J Ballinger, Mary Lou Smith, Elda Railey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancerBryan P Schneider, Kenneth A Kesler, Jo Ann Brooks, et al.
Critical Reviews in Oncology/Hematology|April 24, 2025
Review of the contribution of clinical and genetic factors to the racial disparity in taxane-induced peripheral neuropathyNam Nguyen-Hoang, Maisa Nazzal, Bryan P Schneider, et al.
Scientific Reports|July 2, 2021
Identification of germline cancer predisposition variants during clinical ctDNA testingLeigh Anne Stout, Nawal Kassem, Cynthia Hunter, et al.
Frontiers in Genetics|January 22, 2013
Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathwaysKelly N Holohan, Debomoy K Lahiri, Bryan P Schneider, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
NPJ Genomic Medicine|October 13, 2023
Clinically significant germline pathogenic variants are missed by tumor genomic sequencingLeigh Anne Stout, Cynthia Hunter, Courtney Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158Tarah J Ballinger, Guanglong Jiang, Nawal Kassem, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 16, 2015
Incremental prognostic value of echocardiographic strain and its association with mortality in cancer patientsIsaac B Rhea, Sarada Uppuluri, Stephen Sawada, et al.
Scientific Reports|August 17, 2024
Optimization of a human induced pluripotent stem cell-derived sensory neuron model for the in vitro evaluation of taxane-induced neurotoxicityErica L Cantor, Fei Shen, Guanglong Jiang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 30, 2023
Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic DevelopmentTimothy A Yap, Zsofia K Stadler, Leigh Anne Stout, et al.
NPJ Breast Cancer|October 8, 2024
Discerning the impact of ctDNA detection on patient decision-making in early-stage breast cancerTarah J Ballinger, Mary Lou Smith, Elda Railey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancerBryan P Schneider, Kenneth A Kesler, Jo Ann Brooks, et al.
Critical Reviews in Oncology/Hematology|April 24, 2025
Review of the contribution of clinical and genetic factors to the racial disparity in taxane-induced peripheral neuropathyNam Nguyen-Hoang, Maisa Nazzal, Bryan P Schneider, et al.
Scientific Reports|July 2, 2021
Identification of germline cancer predisposition variants during clinical ctDNA testingLeigh Anne Stout, Nawal Kassem, Cynthia Hunter, et al.
Frontiers in Genetics|January 22, 2013
Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathwaysKelly N Holohan, Debomoy K Lahiri, Bryan P Schneider, et al.
Pageof 12